The funds industry has remained tight-lipped on the EU’s regulatory review of alternative investment funds for fear of unnecessary change, reports Fiona Nicolson. however, others see an opportunity to bring alternative investments to a wider range of investors.
Patrick Thomson, JP Morgan Asset Management’s regional chief executive, tells Funds Europe about his military service, industry consolidation and the importance of ESG.
Asset managers have a huge appetite for the development of digital-asset services – but they may question the technical ability of both themselves, and incumbent service providers, to deliver, writes Nick Fitzpatrick.
A non-executive director joined a recent Funds Europe webinar to discuss a product governance report produced in partnership with Caceis. Where do asset managers’ priorities lie when crafting product strategies and fund governance post-Covid-19?
A recent Funds Europe webinar in association with Jersey Finance discussed Jersey’s strength as a politically stable fund regime.
In a broader government initiative to make Germany a more attractive domicile for investments funds, the German legislator has introduced a regime designed to promote the formation of development impact funds (Entwicklungsförderungsfonds, or EF-Funds), which will come into force on August 2, 2021.
Funds that meet the EU’s highest requirements on ESG disclosure could come to represent half of the region’s total assets under management (AUM) in just the next 12 months.
Regulators have increased their focus on liquidity risk in debt funds. Austin Brady of Waystone explains that this prompted Waystone to increase its loans expertise in order to help clients successfully launch loan funds in Ireland or Luxembourg.
Asset managers and other market participants are unlikely to see reduced market data costs in the EU under plans for a ‘consolidated tape’ – the digital, real-time publication of market data.
The UK financial regulator said it would bring more clarity to investors about the future performance of investment products that are currently designed to comply with the EU’s ‘Priips’ rules.
